ARCHIVES

AHRQ Draft Report Finds No Benefit For Biomarker Testing In Oncology

This article is from The Cancer Letter archive.

Vol. 36 No. 04 | February 5, 2010

Download PDF Visit The Full Archive

Related Articles

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

Reinventing NCI: Clinical Trials System Changes Not Easy Or Quick, Klausner Says; NCAB Members, Others, Sound Off On Group’s Report

October 10, 1997

NCAB Supports ACS Effort To Work With Centers

March 1, 1991

NIH selects nine scientists for Pioneer Awards.

October 1, 2004

Better Access Key To Higher Survival For African-Americans With Colon Cancer

August 30, 2002

Bush To Propose Increase for Cancer Screening, FDA Generics Reviews

January 31, 2003